X.-J. Yang et al. / Tetrahedron 63 (2007) 5643–5648
5647
3020, 2983, 2955, 1615, 1546, 1501, 1448, 1388, 1350,
1H NMR (CDCl3): d 6.75 (1H, d, J¼5.7 Hz), 5.13 (1H, d,
J¼5.7 Hz), 4.20 (1H, br s), 1.95–1.61(2H, m), 1.38 (3H,
s), 0.92 (3H, t, J¼6.3 Hz). 19F NMR (CDCl3): d ꢂ67.4
(2F, m), ꢂ116.8 (2F, m), ꢂ121.2 (2F, m). EIMS (m/z, %):
308 (M+, 2), 293 (M+ꢂMe, 13), 279 (M+ꢂEt, 100). Anal.
Calcd for C10H11ClF6N2: C, 38.91; H, 3.59; N, 9.08. Found:
C, 38.74; H, 3.42; N, 8.99.
1
1313, 1222, 1193, 1133, 1094, 1069, 742 cmꢂ1. H NMR
(CDCl3): d 6.93 (1H, d, J¼6.6 Hz), 5.37 (1H, d, J¼
6.6 Hz), 4.82 (1H, q, J¼6.0 Hz), 3.62 (1H, br s), 1.57 (3H,
d, J¼6.0 Hz). 19F NMR (CDCl3): d ꢂ71.8 (3F, m). EIMS
(m/z, %): 164 (M+, 22), 149 (M+ꢂMe, 100). Anal. Calcd
for C6H7F3N2: C, 43.91; H, 4.30; F, 34.73; N, 17.07. Found:
C, 43.95; H, 4.32; F, 34.78; N, 17.01.
4.3.5. 2-Heptafluoropropyl-1,5-diazaspiro[5.5]undeca-
1,3-diene (2h). White solid, mp: 71–73 ꢀC. IR (KBr):
3277, 2942, 1628, 1535, 1352, 1247, 1197, 1116, 892,
4.3. The reaction of 3 with ammonia and ethyl vinyl
ether
1
737 cmꢂ1. H NMR (CDCl3): d 6.79 (1H, d, J¼5.4 Hz),
A mixture of 3 (1 mmol) and ZnCl2 (1 mmol) in THF
(10 mL) was stirred under ammonia atmosphere for 2 h at
room temperature. Then a solution of ethyl vinyl ether
(1.5 mmol) in THF (10 mL) was added dropwise. The result-
ing mixture was stirred at 50 ꢀC under ammonia atmosphere
for a few hours (monitored by 19F NMR). After cooling,
20 mL water was added and the solution was extracted
with ethyl acetate (3ꢁ10 mL). The combined organic layer
was washed with water and dried over anhydrous Na2SO4.
After removal of solvent, the crude product was purified
by column chromatography (ethyl acetate and petroleum
ether) to give 2.
5.21 (1H, d, J¼5.4 Hz), 1.80–1.40 (10H, m). 19F NMR
(CDCl3): d ꢂ80.6 (3F, m), ꢂ118.1 (2F, m), ꢂ127.1 (2F,
m). EIMS (m/z, %): 318 (M+, 17), 275 (100). Anal. Calcd
for C12H13F7N2: C, 45.29; H, 4.12; N, 8.80. Found: C,
45.28; H, 4.05; N, 8.64.
4.3.6. 2-(3-Chloro-1,1,2,2,3,3-hexafluoropropyl)-1,5-di-
azaspiro[5.5]undeca-1,3-diene (2i). White solid, mp: 70–
72 ꢀC. IR (KBr): 3223, 2940, 1625, 1537, 1496, 1305,
1198, 1125, 812 cmꢂ1. 1H NMR (CDCl3): d 6.73 (1H, d, J¼
5.4 Hz), 5.21 (1H, d, J¼5.4 Hz), 1.90–1.40 (10H, m). 19F
NMR (CDCl3): d ꢂ67.3 (2F, m), ꢂ116.8 (2F, m), ꢂ121.2
(2F, m). EIMS (m/z, %): 336 (M++2, 7), 334 (M+, 21), 275
(100). Anal. Calcd for C12H13ClF6N2: C, 43.06; H, 3.92;
N, 8.37. Found: C, 42.93; H, 4.08; N, 7.99. ESI-HR calcd
for C12H13N2ClF6Na+: 357.0563. Found: 357.0564.
The procedure for the reaction of 3 with ammonia and 4 or
5 was similar to the above one.
4.3.1. 2-Propyl-4-trifluoromethyl-1,2-dihydropyrimidine
(2d). Colorless oil. IR (film): 3207, 3039, 2964, 1629, 1542,
1467, 1325, 1191, 1142, 1095, 744 cmꢂ1. 1H NMR (CDCl3):
d 6.92 (1H, d, J¼6.6 Hz), 5.34 (1H, d, J¼6.6 Hz), 4.71 (1H,
t, J¼5.1 Hz), 4.55 (1H, br s), 1.86–1.81 (2H, m), 1.51–1.42
(2H, m), 0.96 (3H, t, J¼6.2 Hz). 19F NMR (CDCl3): d ꢂ71.7
(3F, m). EIMS (m/z, %): 192 (M+, 5), 149 (M+ꢂPr, 100), 123
(M+ꢂCF3, 2). Anal. Calcd for C8H11F3N2: C, 50.00; H, 5.77;
F, 29.66; N, 14.58. Found: C, 50.17; H, 5.88; F, 28.67; N,
14.18.
4.3.7. 2-Propyl-4-(3-chloro-1,1,2,2,3,3-hexafluoro-
propyl)-1,2-dihydropyrimidine (2j). White solid, mp:
45–47 ꢀC. IR (KBr): 3217, 2966, 1626, 1572, 1539, 1467,
1309, 1184, 1126, 990, 837 cmꢂ1 1H NMR (CDCl3):
.
d 6.89 (1H, d, J¼6.6 Hz), 5.32 (1H, d, J¼6.6 Hz), 4.79 (1H,
t, J¼6.3 Hz), 1.87–1.80 (2H, m), 1.50–1.43 (2H, m), 0.96
(3H, t, J¼6.2 Hz). 19F NMR (CDCl3): d ꢂ67.4 (2F, m),
ꢂ116.2 (2F, m), ꢂ121.2 (2F, m). EIMS (m/z, %): 309
(M++1, 15), 308 (M+, 8), 265 (M+ꢂC3H7, 100). Anal. Calcd
for C10H11ClF6N2: C, 38.91; H, 3.59; N, 9.08. Found: C,
39.20; H, 3.56; N, 8.91.
4.3.2. 2-Propyl-4-heptafluoropropyl-1,2-dihydropyrim-
idine (2e). White solid, mp: 44–46 ꢀC. IR (KBr): 3218,
2966, 1626, 1572, 1537, 1462, 1302, 1181, 1128, 837 cmꢂ1
.
4.3.8. 2-iso-Propyl-4-heptafluoropropyl-1,2-dihydropyr-
imidine (2k). White solid, mp: 50–52 ꢀC. IR (KBr): 3215,
1H NMR (CDCl3): d 6.89 (1H, d, J¼6.6 Hz), 5.34 (1H, d,
J¼6.6 Hz), 4.80 (1H, t, J¼6.3 Hz), 4.50–4.00 (1H, br s),
1.91–1.80 (2H, m), 1.52–1.44 (2H, m), 0.98 (3H, t,
J¼6.3 Hz). 19F NMR (CDCl3): d ꢂ80.7 (3F, m), ꢂ117.8
(2F, m), ꢂ127.1 (2F, m). EIMS (m/z, %): 292 (M+, 2), 249
(M+ꢂC3H7, 100). Anal. Calcd for C10H11F7N2: C, 41.11;
H, 3.79; N, 9.59. Found: C, 41.18; H, 3.84; N, 9.44.
1
2941, 1628, 1547, 1501, 1353, 1182, 1121 cmꢂ1. H NMR
(CDCl3): d 6.91 (1H, d, J¼6.3 Hz), 5.31 (1H, d, J¼
6.3 Hz), 4.54 (1H, d, J¼5.7 Hz), 2.24–2.18 (1H, m), 1.04–
0.99 (6H, m). 19F NMR (CDCl3): d ꢂ80.4 (3F, m), ꢂ116.7
(2F, m), ꢂ127.1 (2F, m). EIMS (m/z, %): 292 (M+, 4), 275
(100), 249 (M+ꢂC3H7, 38). Anal. Calcd for C10H11F7N2:
C, 41.11; H, 3.79; N, 9.59. Found: C, 40.98; H, 3.85; N, 9.19.
4.3.3. 2,2-Dimethyl-4-heptafluoropropyl-1,2-dihydropyr-
imidine (2f). White solid, mp: 64–66 ꢀC. IR (KBr): 3217,
4.3.9. 2-Methyl-2-ethyl-4-heptafluoropropyl-1,2-dihy-
dropyrimidine (2l). Colorless oil. IR (film): 3260, 2980,
1
1628, 1548, 1504, 1353, 1182, 1121, 900, 735 cmꢂ1. H
1
NMR (CDCl3): d 6.79 (1H, d, J¼6.3 Hz), 5.22 (1H, d,
J¼6.3 Hz), 4.30–3.90 (1H, br s), 1.46 (6H, s). 19F NMR
(CDCl3): d ꢂ80.7 (3F, m), ꢂ118.6 (2F, m), ꢂ127.3 (2F,
m). EIMS (m/z, %): 278 (M+, 9), 263 (M+ꢂCH3, 100), 144
(13). Anal. Calcd for C9H9F7N2: C, 38.68; H, 3.26; N,
10.07. Found: C, 38.74; H, 3.37; N, 9.91.
1632, 1542, 1230, 1184, 1120 cmꢂ1. H NMR (CDCl3):
d 6.75 (1H, d, J¼5.7 Hz), 5.13 (1H, d, J¼5.7 Hz), 4.20
(1H, br s), 1.95–1.61 (2H, m), 1.38 (3H, s), 0.92 (3H, t,
J¼6.2 Hz). 19F NMR (CDCl3): d ꢂ80.6 (3F, m), ꢂ118.1 (2F,
m), ꢂ127.7 (2F, m). EIMS (m/z, %): 277 (M+ꢂMe, 24), 265
(M+ꢂEt, 100). Anal. Calcd for C10H11F7N2: C, 41.10; H,
3.79; N, 9.58. Found: C, 40.97; H, 3.73; N, 9.46.
4.3.4. 2-Methyl-2-ethyl-4-(3-chloro-1,1,2,2,3,3-hexafluoro-
propyl)-1,2-dihydropyrimidine (2g). Colorless oil. IR
4.3.10. 2-Methyl-2-propyl-4-heptafluoropropyl-1,2-di-
hydropyrimidine (2m). White solid, mp: 48–50 ꢀC. IR
(film): 3264, 2978, 1631, 1542, 1184, 1125, 840, 811 cmꢂ1
.